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Predictors of 30-day Mortality and 90-day Functional Recovery 
after Primary Pontine Hemorrhage
The factors related to death and functional recovery after primary pontine hemorrhage 
(PPH) in Koreans has not been well defined. The authors sought to identify independent 
predictors of death and functional recovery after PPH using data obtained at a single 
institute. Data were collected retrospectively on 281 patients with PPH admitted to the 
Stroke Unit at our hospital between January 1, 2000 and December 31, 2009. Multivariate 
logistic regression analysis was used to evaluate the associations between selected variables 
and 30-day mortality and 90-day functional recovery after PPH. One-hundred and ten 
patients (39.1%) died within 30 days of PPH and 27 patients (9.6%) achieved functional 
recovery within 90 days. By multivariate analysis, unconsciousness, dilated pupils, 
abnormal respiration, systolic blood pressure < 100 mmHg, hydrocephalus, and 
conservative treatment were found to be predictors of 30-day mortality, whereas 
consciousness, intact motor function, no history of hypertension or diabetes mellitus, 
intact eye movement, a hematoma volume of < 5 mL, no ventricular hemorrhage, and 
normally sized ventricle were found to be predictors of 90-day functional recovery. The 
present findings suggest that systolic hypotension of less than 100 mmHg may predict 30-
day mortality and a history of underlying hypertension and diabetes mellitus may predict 
90-day functional recovery.
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INTRODUCTION
Primary pontine hemorrhage (PPH) is extremely rare in patients 
with hemorrhagic stroke, and accounts for only about 5%-10%   
of intracranial hemorrhages. PPH has an incidence of 2-4 per 
100,000 of the population per annum (1-3), and reported mor-
tality rates vary widely from 30% to 90% (4-6). The classical clini-
cal features of PPH at presentation are; coma, quadriplegia, 
ophthalmoparesis, and pinpoint pupils (4, 7). In the past, PPH 
were accepted as fatal, but computed tomography (CT) allows 
now small PPH to be defined, and thus, mortality rates have de-
creased (8). Continuous and numerous efforts have been made 
to improve the outcome of patients with PPH, and developments 
in the stereotactic surgery and microsurgery field have undoubt-
edly improved outcomes (9, 10). However, PPH does not have a 
uniform prognosis, and varies from early death to long-term 
survival without neurological deficits (7). Accordingly, studies 
on decisive factors that lead to early death or a better outcome 
are useful in clinical practice. In recent studies, a fatal outcome 
was reported in patients with coma on admission, pupillary ab-
normalities, intraventricular extension, hydrocephalus, or a large 
hematoma (4, 8). Furthermore, Murata et al. (4) and Wessels et 
al. (2) reported a significant correlation between death and age. 
However, the numbers of PPH patients enrolled in previous re-
ports were relatively small, and precise statistical analyses were 
lacking. In Korea, although several reports have been published 
on the clinical outcomes and prognostic factors of PPH, only 
one study on 41 patients utilized multivariate analysis to identi-
fy prognostic factors (11). Despite the increasing prevalence of 
ischemic stroke attributed to a rapid westernization of lifestyle, 
PPH is being increasingly diagnosed in Korea (12, 13). Further-
more, studies undertaken to identify predictors of outcome have 
largely been performed in the Western countries or in Japan (1-
5, 8). Accordingly, the factors related to death and functional 
recovery after PPH in the Korean population has not been well 
defined.
  To evaluate the effectivenesses of treatment strategies, and to 
optimize the managements of individuals in accord with estab-
lished prognostic factors, reliable predictors of death and func-
tional outcome should be identified. Using previously estab-
lished putative prognostic variables obtained from the literature 
and the results of our single institute-based multivariate analy-
sis, we sought to identify independent predictors of death and 
functional recovery after PPH in the Korean population based 
on experiences at a single institute.Jang JH, et al.  •  Primary Pontine Hemorrhage
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MATERIALS AND METHODS
Data collection
Between January 1, 2000 and December 31, 2009, 322 patients 
with a diagnosis of PPH were admitted to the Stroke Unit at our 
hospital (a university hospital, serving a population of about 
1,500,000 people). Of these 322 patients, 281 had available med-
ical and radiological records which met the inclusion criteria, 
and these patients constituted our study cohort. We extracted 
all patient-related data from a computerized database (PACS; 
m-view
TM, Marosis Corporation). Three clinical research coor-
dinators independently extracted and recorded patient informa-
tion using a structured form. To preserve patient confidentiality, 
patient identifiers were omitted from the collated data set. The 
inclusion criteria applied were; a diagnosis of PPH verified by 
CT or magnetic resonance imaging (MRI) and admission to the 
stroke unit within 24 hr of symptom onset. As recommended by 
the Stroke Council of the American Heart Association (SCAHA) 
(14), selected patients underwent conventional angiography to 
identify secondary causes of intracerebral hemorrhage. Patients 
with hemorrhage secondary to head trauma, a ruptured cere-
bral aneurysm, an arteriovenous malformation, a tumor, bleed-
ing diathesis, or a hemorrhagic infarction were excluded. 
Epidemiologic characteristics 
Of the baseline variables recorded, we selected age, sex, cigarette 
smoking and alcohol intake histories, body mass index (BMI), 
diabetes mellitus, hypertension, hyperlipidemia, hepatopathy, 
and a family history of stroke because according to the literature 
they are the most epidemiologically relevant prognostic indica-
tors (1-5, 8, 11). Historical features were dichotomized as pres-
ent or absent; these included current smoking or a history of 
smoking (≥ 10 cigarettes/day, ≥ 6 months), and alcohol intake 
(≥ 46 g/day, 3 days/week) (15). BMI was defined as weight in 
kilograms divided by height in meters squared.
Clinical characteristics
Prodromal symptoms reported by patients or their relatives were 
noted. In addition, we selected the following potential clinically 
prognostic indicators based on literature accounts (1-5, 8, 11); 
consciousness at admission, pupillary reflex, motor weakness, 
ophthalmoparesis, violent shivering, abnormal posture to nox-
ious stimulation, hyperthermia, abnormal respiration, seizure, 
and systolic blood pressure. For statistical analysis, patients were 
classified as conscious, stuporous, or in coma on admission. 
Radiologic characteristics
Cranial CTs were performed on admission. All radiologic fea-
tures were available for analysis, that is, volume of hemorrhage 
(< 5 mL vs ≥ 5 mL), location of hemorrhage, ventricular exten-
sion, and hydrocephalus. Hemorrhagic volumes were measured 
using the ellipsoid formula (4/3π × A × B × C) where A, B and C 
represent the respective radii in three dimensional images (16). 
Hemorrhages where divided into three types (dorsal, ventral, 
and massive), according to the CT classification of Chung and 
Park (6). Hematomas were classified as dorsal when the loca-
tion of the PPH was uni- or bilateral tegmental, sparing the base 
pontis, as ventral when the hematoma occupied the ventral base 
pontis and the junction between the bilateral tegmentum, and 
as massive when hematoma occupied the base pontis and the 
bilateral tegmentum with extension to the midbrain. Two neu-
roradiologists individually conducted the radiologic review to 
diagnose PPH and determine their types.
Treatment modality
Patients were treated in accord with a treatment algorithm used 
at our institution. Surgical approaches were individualized based 
on site, PPH size, and associated intraventricular hemorrhage 
or hydrocephalus. The techniques utilized included; suboccipi-
tal craniotomy (CO), suboccipital craniectomy (CE), CT-guided 
stereotactic hematoma evacuation, and/or extraventricular drai-
nage (EVD). The attending neurosurgeon decided whether to 
implant a bone flap (CO or CE) depending on the intra-opera-
tive presence of cerebellar swelling after PPH removal. EVD was 
performed alone or combined with open surgery or stereotac-
tic evacuation for intracranial pressure (ICP) control, particu-
larly in the setting of hydrocephalus or intraventricular hemor-
rhage. When an intraventricular catheter was used to monitor 
ICP, cerebrospinal fluid (CSF) drainage was accomplished by 
intermittent drainage for short periods in response to ICP eleva-
tion. All patients (medical and surgical) were cared for in a neu-
rosurgical intensive care unit until they were considered stable 
enough to move to a general unit. Hypertension was regulated 
early during the course of therapy, by setting a target maximal 
systolic blood pressure (SBP). During the first 24 hr, labetalol was 
initial administered to maintain an SBP of < 160 mmHg, despite 
the risk of bradycardia posed by labetalol. We also used contin-
uous intravenous nicardipine or nitroprusside anti-hyperten-
sive therapy when blood pressure was not controlled by labet-
alol or hydralazine. During the next 48 to 72 hr, the target SBP 
was usually set at 140 mmHg, and enteral anti-hypertensives 
were started when SBP was maintained below this level. We also 
used a hypertonic agent (mannitol) when CT indicated a mass 
effect or when clinical symptoms showed increased ICP signs, 
such as severe headache with vomiting and decreased menta-
tion. Mannitol was initially administered at 0.6 to 1.0 g/kg intra-
venously, followed by 0.25-0.5 g/kg every 4 hr for 4 days, and then 
tapered over 2 days. Treatment included invasive monitoring of 
ICP when indicated. Using an ICP monitor (infrared parenchy-
mal catheter, Camino, Integra Life Science Corporation, Plains-
boro, NJ, USA), an ICP elevation was defined as > 20 mmHg and 
cerebral perfusion pressure was maintained at 70 to 100 mmHg.Jang JH, et al.  •  Primary Pontine Hemorrhage
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Assessments of outcome
Patients were followed for at least 90 days after PPH. Outcomes 
were assessed as mortality within 30 days of symptom onset 
(post-PPH), and as functional statuses in patients that survived 
for more than 90 days post-PPH (17), which were assessed us-
ing the Modified Rankin’s Scale (MRS) as follows; no symptom 
(MRS 0), symptomatic but no disability (MRS 1), mild disability 
(MRS 2), moderate disability with independent walking (MRS 3), 
severe disability (MRS 4), bedridden state (MRS 5), and death 
(MRS 6). For statistical purposes, patients were assigned to two 
outcome category groups, namely, the “functional recovery” 
group (MRS 0, 1, 2, 3), members of which were functionally in-
dependent, and the “non-functional recovery” group (MRS 4, 5, 
6). Information on mortality and functional outcome was cate-
gorized using medical records, information obtained from fam-
ily members by telephone interviews, or by direct patient ex-
aminations conducted at our outpatient department after dis-
charge. 
Statistical analysis
Our primary aim was to identify associations between the se-
lected variables and 30-day mortality and 90-day functional re-
covery. Univariate analysis was used initially to identify possible 
relations between outcome and each of the potential prognostic 
factors using the chi-squared test. Subsequently, multivariate 
logistic regression analysis was used to identify those variables 
independently associated with functional recovery and mortal-
ity. Kaplan-Meier survival curve analysis was used to depict cu-
mulative mortalities. The analysis was performed using SPSS 
Ver. 12.0 for Windows (SPSS Institute, Inc., Chicago, IL, USA), 
and statistical significance was accepted for P values of < 0.05. 
Ethics statement
This retrospective and a single institute-based study protocol 
was approved by the Institutional Review Board (MSH 2008-010) 
at our hospital and informed consent was obtained from all the 
subjects if survived or one of family members if died or uncon-
scious for collection of clinical data. The data presented in this 
report has never been published or submitted for publication 
wholly or in part.
RESULTS
Two-hundred and eighty-one eligible records were identified 
and analyzed during the course of this study. Of the 281 study 
subjects, 202 (71.9%) were male and 79 (28.1%) were female. 
Mean patient age was 56.4 ± 16.3 yr (range 27-85 yr). The mortal-
ity rate at 30 days after PPH was 39.1% (n = 110), and 140 deaths 
(49.8%) occurred within 3 months, 162 (57.7%) within 6 months, 
and 182 (64.8%) within 12 months. Fig. 1 shows cumulative mor-
talities during the at least 6 month follow-up period. For all study 
subjects, the rate of a good functional recovery at 90 days was 
9.6% (n = 27), and at 90 days post-PPH, the rate of a good func-
tional recovery was 19.1% among the 141 that survived at 90 days 
post-PPH. Eighty-six (30.6%) of the study subjects underwent 
surgical intervention and 195 (69.4%) received initial conserva-
tive treatment. The most frequently used surgical technique was 
CT-guided stereotactic PPH evacuation, which was used in 114 
patients (40.7%).
 
Thirty-day mortality
Univariate analysis showed that the following variables were sig-
nificantly associated with death during the first 30 days post-
PPH (Tables 1-4); a previous history of diabetes mellitus, hyper-
tension, unconsciousness at admission, dilated pupils, limb 
weakness, ophthalmoplegia, an abnormal posture to noxious 
stimulation, abnormal respiration, systemic hypotension at ad-
mission, a hemorrhage volume ≥ 5 mL, a massive hemorrhage, 
ventricular extension of hemorrhage, presence of hydrocepha-
lus, and conservative treatment. For surgically treated patients, 
surgical technique and time to surgery were not found to be as-
sociated with 30-day mortality.
  Multivariate logistic regression analysis was performed on the 
variables identified by univariate analysis results and on those 
mentioned in the literature. Results are presented in Table 5. 
Multivariate analysis showed that a comatose mentality, dilated 
pupils, abnormal respiration, a SBP < 100 mmHg at admission, 
hydrocephalus, and conservative treatment were independent-
ly associated with 30-day mortality. Other variables found to be 
associated with 30-day mortality by univariate analysis were not 
found to be associated by multivariate analysis.
Ninety-day functional recovery
At 90 days after diagnosis of PPH, there were 141 survivors (50.2 
%), and of these survivors, 27 (9.6% of all patients) achieved func-
tional recovery (MRS 0, 1, 2, 3), and 254 (90.4% of all patients) 
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Fig. 1. Cumulative mortality curve. The one-year mortality rate was 64.8% and 2-yr 
mortality rate 72.3%.Jang JH, et al.  •  Primary Pontine Hemorrhage
http://jkms.org   103 DOI: 10.3346/jkms.2011.26.1.100
achieved a non-functional recovery (MRS 4, 5). Of the selected 
variables, the following were found to be significantly associat-
ed with functional recovery by univariate analysis (Tables 1-4); 
BMI < 25, absence of history of underlying diabetes, hyperten-
sion, consciousness, normal reactive pupils, normal respiration, 
a hematoma volume of < 5 mL, basal and dorsal type of hemor-
rhage, and the absence of limb weakness, ophthalmoplegia, an 
abnormal postural response to pain, and hydrocephalus. Surgi-
cal treatment which was associated with 30-day mortality was 
not associated with functional recovery. Additionally, it was ob-
served that in the surgically treated patients, surgical technique 
and time to surgery were not associated with good functional 
recovery by univariate analysis.
  Multivariate logistic regression analysis showed that the fol-
lowing eight admission variables were independently associat-
ed with a good functional recovery at 90 days post-PPH (Table 
6); conscious mentality, a hematoma volume of < 5 mL, and the 
absence of ventricular extension of blood, hydrocephalus, limb 
weakness, a history of underlying diabetes, hypertension, and 
ophthalmoplegia. Other variables found to be associated with 
good functional recovery at 90 days post-PPH by univariate anal-
ysis were not found to be associated by multivariate analysis.
DISCUSSION
This is the largest multivariate analysis performed to date at a 
single institute in Korea on the predictors of outcome after PPH. 
Only one multivariate logistic analysis has been previously con-
ducted to determine the predictors of survival and functional 
outcome after PPH by Jung et al. in 2007 (11). The previous study 
was performed on 41 PPH patients, and it was found that trans-
verse hematoma diameter and initial consciousness were inde-
pendently associated with survival rate. In addition, it was sug-
gested that long-term outcome is influenced by initial conscious-
ness, transverse diameter, antero-posterior diameter, and he-
matoma volume. However, surgical treatment was not included 
among the treatment modalities-all patients were treated con-
servatively. We believe this is why hematoma volume was found 
to be associated with survival by Jung et al. (11). On the other 
hand, we found no association between hematoma volume and 
survival. We treated PPH patients with a volume exceeding 5 mL 
by surgical intervention, and we believe that these surgical in-
terventions are responsible for the discrepancy between our re-
sult and that of Jung et al. (11).
  The efficacy of surgery in PPH patients remains debatable. 
Table 1. Epidemiologic characteristics of patients and univariate analysis of predictors of 30-day mortality and 90-day functional recovery after primary pontine hemorrhage         
(N = 281)
Variables
No. of patients  
(%)
30-day Mortality  
(%)
P value
90-day Functional 
recovery (%)
   P value
Age (yr)
   40-54
   55-69
   70 ≤
  86 (30.6)
112 (39.9)
  83 (29.5)
  31 (36.0)
  45 (40.2)
  34 (41.0)
0.728
    9 (10.5)
11 (9.8)
  7 (8.4)
   0.823
Gender
   Male
   Female
202 (71.9)
  79 (28.1)
  77 (38.1)
  33 (41.8)
0.564
20 (9.9)
  7 (8.9)
   0.628
Smoking
   Yes
   No
189 (67.3)
  92 (32.7)
  80 (42.3)
  30 (32.6)
0.088
17 (9.0)
  10 (10.9)
   0.381
Habitual alcohol consumption
   Yes
   No
158 (56.2)
123 (43.8)
  62 (39.2)
  48 (39.0)
0.981
14 (8.9)
  13 (10.6)
   0.425
Body mass index (kg/m
2)
   < 25
   ≥ 25
  88 (31.3)
193 (68.7)
  33 (37.5)
  77 (39.9)
0.835
  11 (12.5)
16 (8.3)
   0.008
Diabetes mellitus
   Yes
   No
169 (60.1)
112 (39.9)
  82 (48.5)
  28 (25.0)
0.012
12 (7.1)
  15 (13.4)
   0.001
Hypertension
   Yes
   No
212 (75.4)
  69 (24.6)
101 (47.6)
    9 (13.0)
0.002
15 (7.1)
  12 (17.4)
< 0.001
Hyperlipidemia
   Yes
   No
174 (61.9)
107 (38.1)
  71 (40.8)
  39 (36.4)
0.283
16 (9.2)
  11 (10.2)
   0.489
Family history of stroke
   Yes
   No
185 (65.8)
  96 (34.2)
  75 (40.5)
  35 (36.5)
0.206
18 (9.7)
  9 (9.4)
   0.887
Hepatopathy
   Yes
   No
  52 (18.5)
229 (81.5)
  22 (42.3)
  88 (38.4)
0.152
    6 (11.5)
21 (9.2)
   0.226Jang JH, et al.  •  Primary Pontine Hemorrhage
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Table 2. Clinical manifestations of patients and univariate analysis of predictors of 30-day mortality and 90-day functional recovery after primary pontine hemorrhage (N = 281)
Variables
No. of patients  
(%)
30-day Mortality  
(%)
P value
90-day Functional  
recovery (%)
P value
Consciousness
   Conscious
   Stupor
   Coma
  61 (21.8)
103 (36.7)
117 (41.6)
  2 (3.3)
  19 (18.5)
  89 (76.1)
< 0.001
  25 (41.0)
  2 (2.0)
  0 (0.0)
< 0.001 
Pupil
   Reactive
   Pinpoint
   Dilated
143 (50.9)
  91 (32.4)
  47 (16.7)
  8 (5.6)
  55 (60.4)
    47 (100.0)
< 0.001
    27 (100.0)
  0 (0.0)
  0 (0.0)
< 0.001
Motor weakness
   Absent
   Quadriparesis
   Paraparesis
   Hemiparesis
23 (8.2)
211 (75.1)
  7 (2.5)
  41 (14.5)
  0 (0.0)
101 (47.9)
    3 (42.9)
    6 (14.6)
< 0.001
    23 (100.0)
  0 (0.0)
    1 (14.3)
  3 (7.3)
< 0.001
EOM limitation
   Present
   Absent
196 (69.8)
  85 (30.2)
  99 (50.5)
  11 (12.9)
0.001
  4 (2.0)
  23 (27.1)
< 0.001
Violent shivering
   Present
   Absent
24 (8.5)
257 (91.5)
    8 (33.3)
102 (39.7)
0.294
    3 (12.5)
24 (9.3)
0.110
Decorticated posture
   Present
   Absent
18 (6.4)
263 (93.6)
  17 (94.4)
  93 (35.4)
< 0.001
  0 (0.0)
  27 (10.3)
< 0.001
Decerebrated posture 
   Present
    Absent
13 (4.6)
268 (95.4)
    13 (100.0)
  97 (36.2)
< 0.001
  0 (0.0)
  27 (10.1)
< 0.001
Hypothermia
   Present
   Absent
12 (4.3)
269 (95.7)
    4 (33.3)
106 (39.4)
0.226
  1 (8.3)
26 (9.7)
0.845
Abnormal respiration
   Present
   Absent
  46 (16.4)
235 (83.6)
  44 (95.7)
  66 (28.1)
< 0.001
  0 (0.0)
  27 (11.5)
< 0.001
Blood pressure (mmHg)
   > 160
   100-160
   < 100
187 (66.5)
  94 (33.5)
  48 (17.1)
  58 (31.0)
  30 (31.2)
  32 (66.7)
0.003
17 (9.1)
  6 (6.4)
  4 (8.3)
0.217
Seizure
   Present
   Absent
27 (9.6)
254 (90.4)
  10 (37.0)
100 (39.4)
0.871     3 (11.1)
24 (9.4)
0.554
EOM, Extra-ocular movement.
Table 3. Characteristics of pontine hemorrhage and univariate analysis of predictors of 30-day mortality and 90-day functional recovery after primary pontine hemorrhage (N = 281)
Variables
No. of patients  
(%)
30-day Mortality 
(%)
 P value
  90-day Functional  
  recovery (%)
 P value
Volume of hemorrhage
   < 5 mL
   ≥ 5 mL
104 (37.0)
177 (63.0)
11 (10.6)
99 (55.9)
< 0.001
  25 (24.0)
  2 (1.1)
< 0.001
Main location of hemorrhage
   Massive
   Ventral
   Dorsal
133 (47.3)
  81 (28.8)
  67 (23.8)
89 (66.9)
20 (24.7)
1 (1.5)
< 0.001
  5 (3.8)
  12 (14.8)
  10 (14.9)
   0.003
Ventricular extension
   Present
   Absent
111 (39.5)
170 (60.5)
54 (48.6)
56 (32.9)
   0.037
10 (9.0)
  17 (10.0)
   0.556
Location of ventricular extension (n = 111)
   3rd ventricle
   4th ventricle
   Lateral ventricle
   Combination
  28 (25.2)
  56 (50.5)
  14 (12.6)
  13 (11.7)
14 (50.0)
25 (44.6)
  8 (57.1)
  7 (53.8)
   0.887
  2 (7.1)
  4 (7.1)
    2 (14.3)
    2 (15.4)
   0.341
Hydrocephalus
   Present
   Absent
  79 (28.1)
202 (71.9)
43 (54.4)
67 (33.2)
   0.027
  4 (5.0)
  23 (11.3)
   0.048Jang JH, et al.  •  Primary Pontine Hemorrhage
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Fewel et al. (18) and Manno et al. (19) suggested that surgical 
management offers no benefit to patients with a brainstem hem-
orrhage, whereas Han et al. (20) and Hara et al. (9) advocated 
the efficacy of the surgical treatment of PPH. In the present study, 
surgical treatment is associated with a low 30-day mortality by 
univariate and multivariate analysis, but not with better func-
tional recovery at 90-day post-PPH. Although a controlled com-
parative clinical trial is needed to determine the efficacy of the 
surgical treatment for PPH, such a trial is likely to pose ethical 
problems regarding which can be originated from weak evi-
dence. In fact, our results and those of Hara et al. (9) are some-
what limited because randomization was not performed and 
because of selection bias. Furthermore, surgical therapy is not 
standard therapy for PPH and is probably limited to selected 
indications at specialized centers. For example, at our institute, 
large or dorsally exophytic hematomas tend to be treated by sur-
gery, such as, by suboccipital craniotomy or craniectomy and 
CT-guided stereotactic aspiration. And, it was thought to be same 
reason that intraventricular extension of hemorrhage was not 
correlated with outcome. 
  Some reports have suggested that intraventricular PPH exten-
sion is associated with a fatal outcome (4, 8). However, the present 
study shows that intraventricular PPH extension is not associated 
with high 30-day mortality, but associated with poorer 90-day func-
tional recovery. This result is believed to be due to the frequent 
extraventricular drainage conducted in cases with intraventric-
ular hemorrhage. In terms of acute hydrocephalus, Murata et al. 
(4) found no improvement in outcome when acute hydroceph-
alus in PPH was treated by extraventricular drainage. Similarly, 
we found that acute hydrocephalus was associated with a high 
30-day mortality rate despite frequent extraventricular drainage. 
  Although many studies have reported that hypertension is 
the most common cause of PPH (1-3, 7, 8), its effect on clinical 
outcome remains debatable. In the present study, it is interest-
ing to find that a systolic hypotension of < 100 mmHg at admis-
sion was associated with a high risk of mortality within 30 days. 
Table 4. Treatment modalities adopted and univariate analysis of predictors of 30-day mortality and 90-day functional recovery after primary pontine hemorrhage (N = 281)
Parameters
No. of patients  
(%)
30-day Mortality  
(%)
P value
  90-day Functional  
  recovery (%)
P value
Treatment modality
   Conservative 
   Surgery
195 (69.4)
  86 (30.6)
94 (48.2)
16 (18.6)
0.011
18 (9.2)
    9 (10.5)
0.887
Surgical technique (n = 86)
   Craniotomy and hematoma removal
   Craniectomy and hematoma removal
   Stereotactic evacuation
   Ventriculostomy alone
   Combination
  2 (2.3)
  16 (18.6)
  35 (40.7)
  14 (16.3)
  19 (22.1)
  1 (50.0)
  4 (25.0)
  9 (25.7)
0 (0.0)
  2 (10.5)
0.684
  0 (0.0)
  1 (6.3)
    6 (17.1)
    2 (14.3)
  0 (0.0)
0.581
Time to surgery (n = 86)
   < 24 hr
   ≥ 24 hr
  77 (89.5)
    9 (10.5)
14 (18.2)
  2 (22.2)
0.319
    8 (10.4)
    1 (11.1)
0.847
Table 5. Multivariate analysis of predictors of 30-day mortality after primary pontine 
hemorrhage
Predictors 
Odd ratio  
(95% confidence interval)
 P value
Consciousness
   Stupor vs conscious
   Coma vs conscious
   Coma vs stupor
1.84 (0.83-2.16)
7.32 (3.60-15.14)
4.35 (2.82-9.64)
0.088
< 0.001
0.012
Light reflex of pupil
   Dilated vs reactive
   Pinpoint vs reactive
   Dilated vs pinpoint
8.37 (5.06-16.32)
1.47 (0.89-2.00)
4.21 (2.54-8.66)
< 0.001
0.254
0.018
Respiration 
   Abnormal vs normal 5.64 (3.47-7.51) 0.002
Blood pressure
   > 160 mmHg vs 100-160 mmHg
   < 100 mmHg vs > 160 mmHg
   < 100 mmHg vs 100-160 mmHg
1.28 (0.74-1.98)
3.52 (2.85-5.61)
3.68 (2.56-6.40)
0.846
0.026
0.022
Hydrocephalus
   Present vs absent 2.98 (1.84-5.02) 0.038
Treatment modalities
   Conservative care vs surgery 3.06 (1.64-6.82) 0.033
Table 6. Multivariate analysis for predictors of 90-day functional recovery after primary 
pontine hemorrhage
Predictors 
Odd ratio  
(95% confidence interval)
 P value
Consciousness
   Conscious vs stupor
   Conscious vs coma
   Stupor vs coma
5.74 (2.50-8.48)
6.38 (3.12-13.74)
1.28 (0.85-1.98)
< 0.001
< 0.001
0.746
Motor weakness
   Absent vs present 3.57 (2.42-6.08) 0.001
History of hypertension
   Absent vs present 3.44 (1.98-6.32) 0.001
History of diabetes mellitus
   Absent vs present 2.52 (1.80-5.12) 0.032
EOM limitation
   Absent vs present 3.27 (2.08-6.13) 0.008
Hematoma volume
    < 5 mL vs ≥ 5 mL 4.54 (2.83-9.51) < 0.001
Ventricular extension
   Absent vs present 3.64 (2.18-7.08) 0.001
Hydrocephalus
   Absent vs present 2.84 (1.79-5.32) 0.030
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On the other hand, Dziewas et al. (1) found that an extremely 
high systolic pressure (> 180 mmHg) at admission was strongly 
associated with death in PPH patients. However, in the present 
study, 51 patients (18.1%) had a systolic blood pressure of > 180 
mmHg at admission, and 18 (35.3%) of these patients died with-
in 30 days, which is similar to the 30-day mortality rate of pati-
ents with as systolic blood pressure of ≤ 180 mmHg. We believe 
that this discrepancy might have been due to the different treat-
ments administered for hypertension and different PPH severi-
ties. In addition, we consider that systolic hypotension at admis-
sion could be explained by rapid brain stem destruction due to 
the effects of hemorrhage in the pons and those of acute hydro-
cephalus, both of which could lead to brainstem herniation. 
  Regarding a history of underlying hypertension, our results 
and those of Balci et al. (3) suggest that it has no effect on surviv-
al in PPH, but Dziewas et al. (1) suggested that underlying hyper-
tension has an effect on survival in PPH. In terms of functional 
recovery, Wessels et al. (2) and Rabinstein et al. (7) suggested 
that a history of hypertension has no effect. However, our results 
and those of Wijdicks et al. (8) suggested that a history of hyper-
tension affected functional recovery. 
  Considering functional recovery, Dziewas et al. (1) reported 
a good recovery rate of 25% among 12 survivors, Rabinstein et 
al. (7) reported a rate of 77% among 36, Wijdicks et al. (8) a rate 
of 47% among 17, Jung et al. (11) a rate of 54.5% among 22, and 
Masiyama et al. (21) a rate of 78% among 14 survivors. Our study 
showed a good recovery rate at 12-month post-PPH of 15.3% 
among all study subjects and 43.4% among 99 survivors, and 
this good functional recovery rate concurs with those of other 
studies. Furthermore, in the present study, we estimated func-
tional recovery using the MRS, but other studies have used the 
Glasgow Outcome Scale (GOS), which could have caused some 
functional outcome differences. Rabinstein et al. (7) suggested 
that cause was a main predictor of outcome in patients with pon-
tine hemorrhage. According to their data, previous histories of 
hypertension, diabetes mellitus, or stroke, and smoking were 
not correlated with a poor outcome at 3 months post-PPH. How-
ever, their study was performed in patients with PPH or second-
ary pontine hemorrhage, such as, that caused by a cavernous 
malformation. In the present study, histories of hypertension 
and diabetes mellitus were found to be associated with poor 
functional recovery. Furthermore, the different objectives of 
studies might be responsible for result differences.
  Other variables at admission, such as, a comatose mentality, 
dilated pupils, abnormal respiration, and systemic hypotension, 
which are considered to indicate life-threatening conditions, 
were found to be associated with 30-day mortality. These con-
ditions could be explained by rapid brain stem destruction due 
to the effects of hemorrhage on the reticular activating system 
in the upper third of the pontine tegmentum and the effects of 
acute hydrocephalus. According to the literature, ‘a coma on 
admission’ most reliably predicts a poor outcome. In Kushner 
and Bressman’s series (22), all 6 comatose PPH patients at pre-
sentation died and the 4 non-comatose patients survived. Ma-
siyama et al. (21) reported 3 survivors among 14 comatose pa-
tients, but 11 survivors among 12 non-comatose patients. In a 
study conducted by Wijdicks et al. (8), 21 patients died, which 
all patients were comatose at presentation, and among 17 pa-
tients who survived, only 4 were comatose at admission; Mura-
ta et al. (4) reported 8 survivors among 40 comatose patients at 
admission, but 34 survivors among 40 non-comatose patients. 
These numbers are in a line with our own results. Of 182 patients 
who died during the first year post-PPH, 117 patients were co-
matose patients, and of the 99 survivors at 1-yr follow-up visits, 
no patient was comatose on admission.
  Although this study was largest of its type conducted to date, 
its findings are limited by several shortcomings. First, this retro-
spective study was performed using data obtained at a single in-
stitute and was not conducted on a multi-institutional or a nation-
al basis, and thus, our results may not accurately represent the 
national situation. Second, patients with an extremely severe 
hemorrhage were less likely to have undergone complete evalu-
ation, which would have introduced study bias. Third, it is difficult 
to conclude that surgical treatment is the more effective treatment 
modality in PPH patients due to the lack of non-randomization 
and the selection bias introduce by choosing treatment modali-
ties. Fourth, the means of determining results differed from those 
used in similar studies, for example, the use of GOS or MRS.
  To overcome these limitations, a more comprehensive and 
comparative study, free of ethical problems is required. Never-
theless, it is hoped that knowledge of the predictors of mortality 
and functional recovery identified in the present study will im-
prove patient outcomes and individual patient management.
  In conclusion, this retrospective single institute-based multi-
variate analysis of Korean PPH patients suggests that poor ini-
tial consciousness, dilated pupils, abnormal respiration, system-
ic hypotension at admission, hydrocephalus, and conservative 
treatment independently predict early mortality, and that bet-
ter consciousness, no limb weakness, no history of previous di-
abetes or hypertension, no ophthalmoplegia, a small hemato-
ma volume, no intraventricular extension of hemorrhage, and 
no hydrocephalus more powerfully predict functional recovery 
than the other variables examined. In particular, it is interesting 
to find that a systolic blood pressure < 100 mmHg at admission 
can predict 30-day mortality, and that a history of underlying 
hypertension or diabetes mellitus can predict 90-day functional 
recovery by multivariate logistic analysis.
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AUTHOR SUMMARY
Predictors of 30-day Mortality and 90-day Functional Recovery after Primary 
Pontine Hemorrhage
Ji Hwan Jang, Yun Gyu Song, and Young Zoon Kim
The factors related to death and functional recovery after primary pontine hemorrhage (PPH) in Koreans has not been well defined. 
The authors sought to identify independent predictors of death and functional recovery after PPH using data obtained at a single 
institute. Data were collected retrospectively on 281 patients with PPH admitted to the Stroke Unit at our hospital between 
January 1, 2000 and December 31, 2009. One-hundred and ten patients (39.1%) died within 30 days of PPH and 27 patients 
(9.6%) achieved functional recovery within 90 days. By multivariate analysis, unconsciousness, dilated pupils, abnormal 
respiration, systolic blood pressure < 100 mmHg, hydrocephalus, and conservative treatment were found to be predictors of 30-
day mortality, whereas consciousness, intact motor function, no history of hypertension or diabetes mellitus, intact eye 
movement, a hematoma volume of < 5 mL, no ventricular hemorrhage, and normally sized ventricle were found to be predictors 
of 90-day functional recovery. The present findings suggest that systolic hypotension of less than 100 mmHg predicts 30-day 
mortality, and a history of underlying hypertension and diabetes mellitus predict 90-day functional recovery.